“…The differential for focally increased hepatic activity generally includes misregistration artifact from diaphragmatic motion and metabolic activity within the adjacent bowel (which had been confidently excluded in this case, as there was no evidence of misregistration, no nearby bowel activity of sufficient intensity to account for the hepatic finding, and the focal increased hepatic activity conformed to the shape of the liver in three planes and on the MIP, corresponding to the finding on CT) versus primary or secondary hepatic neoplasm, most likely metastatic lymphoma in this case. When interventional radiology (IR) was consulted for liver biopsy and reviewed the CT findings, IR strongly concurred with the CT interpretation favoring a benign etiology for the CT finding, which had been stable in size for three months, likely related to collateral blood flow, prompting the question, “Could the focal abnormal increased FDG uptake on PET also be due to collateral blood flow, rather than a hypermetabolic mass?” A literature search identified one published report in the thoracic imaging literature of focal liver uptake in this same region on FDG-PET in two lung cancer patients with SVC obstruction ( 1 ). Given the previously reported PET finding and the CT features favoring benignity of the lesion, liver biopsy was deferred in favor of CT followup, which thereafter documented stability of the hepatic finding for 14 months ( Fig.…”